NCT03671421

Brief Summary

The main purpose of this study is to determine if there is a difference in graft re-injury/failure rates between participants that have had an ACL reconstruction with a STG, BPTB or QT autograft. Additionally, to compare quality of life, patient reported outcomes and functional performance after ACL reconstruction with STG, BPTB and QT.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
297

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

September 11, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 14, 2018

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

April 2, 2024

Status Verified

April 1, 2024

Enrollment Period

6.2 years

First QC Date

September 11, 2018

Last Update Submit

April 1, 2024

Conditions

Keywords

Graft choicehamstringquadriceps tendon

Outcome Measures

Primary Outcomes (1)

  • graft re-injury (re-rupture, partial tear) or graft failure

    ) Diagnosis of a complete graft re-rupture requires all of the following criteria to be met: * associated with an acute traumatic event * a definite loss of end point on manual Lachman testing * increased anterior translation \>3 mm * \> or = Grade 2 pivot shift * tear confirmed as complete on MRI or diagnostic arthroscopy * revision ACL reconstruction IS recommended or required 2\) Diagnosis of a partial re-rupture requires all of the following criteria: * suspected meniscal injury or graft tear on history without the clinical characteristics of a complete rupture * tear confirmed as partial by MRI or diagnostic arthroscopy * revision ACL reconstruction is NOT recommended or required 3\) Diagnosis of graft failure will be defined as: * \>/= Gr. 2 pivot shift and/or \>6 mm side-to-side difference on manual Lachman

    24 months

Secondary Outcomes (6)

  • SANE

    24 months

  • Knee laxity

    24 months

  • Concentric maximal strength

    24 months

  • Pain log

    3 weeks post operative

  • ACL-QOL

    24 months

  • +1 more secondary outcomes

Study Arms (3)

Quads tendon

ACTIVE COMPARATOR

The graft tissue will be quadriceps tendon

Procedure: ACL reconstruction - graft choice

Hamstring

ACTIVE COMPARATOR

Semitendinosus and gracilis will be used for graft

Procedure: ACL reconstruction - graft choice

BPTB

ACTIVE COMPARATOR

Bone patellar tendon bone graft to be used.

Procedure: ACL reconstruction - graft choice

Interventions

Use of 3 different ipsilateral autograft options

BPTBHamstringQuads tendon

Eligibility Criteria

Age14 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • \- confirmed diagnosis of a complete primary unilateral ACL rupture based on all of the following:
  • history of a traumatic injury episode
  • physical exam findings of increased anterior translation of the tibia on the femur (Lachman test and/or anterior drawer test)
  • positive pivot shift test
  • patients must be 14 to \</= 50 years (at time of surgery)
  • x-rays showing skeletal maturity (i.e. tibial tubercle fused) and no fractures
  • MRI prior to surgery (note: if the radiologist's report states an incomplete or partial ACL on MRI but the surgeon diagnoses the patient with a complete unilateral tear based on the clinical criteria above, then the patient will be considered eligible. Final eligibility will be determined intra-operatively.)

You may not qualify if:

  • \- ACL rupture on contra-lateral limb
  • Partially torn ACL \*final determination made intra-operatively
  • Concomitant medial collateral, lateral collateral, or posterior collateral ligament tears requiring surgical repair \*final determination made intra-operatively
  • Severe chondromalacia (Grade IV on the ICRS scale) \*final determination made intra-operatively
  • ACL reconstruction using allograft tissue
  • Confirmed connective tissue disorder
  • Unwillingness to be followed for 24 months post-operatively
  • History of rheumatoid arthritis
  • Pregnancy (at the time of surgery)
  • Psychiatric illness that precludes informed consent
  • Unable to speak, read or understand the English language
  • Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pan Am Clinic

Winnipeg, Manitoba, R3M3E4, Canada

Location

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The clinical assessments will be done by someone blinded to the arm of the study the patient is in.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective quasi-randomized clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department head, orthopaedic surgery

Study Record Dates

First Submitted

September 11, 2018

First Posted

September 14, 2018

Study Start

September 11, 2018

Primary Completion

November 30, 2024

Study Completion

November 30, 2024

Last Updated

April 2, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations